| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5948437 | ASTRAZENECA | Pharmaceutical compositions using thiazepine |
May, 2017
(6 years ago) | |
|
US5948437 (Pediatric) | ASTRAZENECA | Pharmaceutical compositions using thiazepine |
Nov, 2017
(6 years ago) | |
Seroquel Xr is owned by Astrazeneca.
Seroquel Xr contains Quetiapine Fumarate.
Seroquel Xr has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Seroquel Xr are:
- US5948437
- US5948437*PED
Seroquel Xr was authorised for market use on 17 May, 2007.
Seroquel Xr is available in tablet, extended release;oral dosage forms.
Seroquel Xr can be used as treatment of schizophrenia.
The generics of Seroquel Xr are possible to be released after 28 November, 2017.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Indication(I-575) | Oct 08, 2011 |
| New Indication(I-574) | Oct 08, 2011 |
| New Dosing Schedule(D-117) | Oct 08, 2011 |
| Pediatric Exclusivity(PED) | Apr 08, 2012 |
| New Indication(I-576) | Oct 08, 2011 |
| New Indication(I-618) | Dec 02, 2012 |
Drugs and Companies using QUETIAPINE FUMARATE ingredient
Market Authorisation Date: 17 May, 2007
Treatment: Treatment of schizophrenia
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of SEROQUEL XR before it's drug patent expiration?
More Information on Dosage
SEROQUEL XR family patents
